176 related articles for article (PubMed ID: 11132157)
21. Molecular defects underlying the Kell null phenotype.
Lee S; Russo DC; Reiner AP; Lee JH; Sy MY; Telen MJ; Judd WJ; Simon P; Rodrigues MJ; Chabert T; Poole J; Jovanovic-Srzentic S; Levene C; Yahalom V; Redman CM
J Biol Chem; 2001 Jul; 276(29):27281-9. PubMed ID: 11375401
[TBL] [Abstract][Full Text] [Related]
22. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
[TBL] [Abstract][Full Text] [Related]
23. The Kell blood group system.
Redman CM; Lee S
Transfus Clin Biol; 1995; 2(4):243-9. PubMed ID: 8542022
[TBL] [Abstract][Full Text] [Related]
24. Kell and XK immunohistochemistry in McLeod myopathy.
Jung HH; Russo D; Redman C; Brandner S
Muscle Nerve; 2001 Oct; 24(10):1346-51. PubMed ID: 11562915
[TBL] [Abstract][Full Text] [Related]
25. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
[TBL] [Abstract][Full Text] [Related]
26. Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype.
Lee S; Russo DC; Reid ME; Redman CM
Transfusion; 2003 Aug; 43(8):1121-5. PubMed ID: 12869119
[TBL] [Abstract][Full Text] [Related]
27. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.
Ji Y; Veldhuisen B; Ligthart P; Haer-Wigman L; Jongerius J; Boujnan M; Ait Soussan A; Luo G; Fu Y; van der Schoot CE; de Haas M
Transfusion; 2015 Feb; 55(2):413-21. PubMed ID: 25156717
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis for the high-incidence antigens of the Kell blood group system.
Lee S; Naime DS; Reid ME; Redman CM
Transfusion; 1997; 37(11-12):1117-22. PubMed ID: 9426633
[TBL] [Abstract][Full Text] [Related]
29. Identification of two new members, XPLAC and XTES, of the XK family.
Calenda G; Peng J; Redman CM; Sha Q; Wu X; Lee S
Gene; 2006 Mar; 370():6-16. PubMed ID: 16431037
[TBL] [Abstract][Full Text] [Related]
30. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.
Lee S; Debnath AK; Redman CM
Blood; 2003 Oct; 102(8):3028-34. PubMed ID: 12842980
[TBL] [Abstract][Full Text] [Related]
31. McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.
Jung HH; Hergersberg M; Vogt M; Pahnke J; Treyer V; Röthlisberger B; Kollias SS; Russo D; Frey BM
Transfusion; 2003 Jul; 43(7):928-38. PubMed ID: 12823753
[TBL] [Abstract][Full Text] [Related]
32. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family.
Hanaoka N; Yoshida K; Nakamura A; Furihata K; Seo T; Tani Y; Takahashi J; Ikeda S; Hanyu N
J Neurol Sci; 1999 May; 165(1):6-9. PubMed ID: 10426139
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells.
Camara-Clayette V; Rahuel C; Lopez C; Hattab C; Verkarre V; Bertrand O; Cartron JP
Biochem J; 2001 May; 356(Pt 1):171-80. PubMed ID: 11336649
[TBL] [Abstract][Full Text] [Related]
34. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
[TBL] [Abstract][Full Text] [Related]
35. New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes.
Silvy M; Callebaut I; Filosa L; Granier T; Chiaroni J; Bailly P
Transfusion; 2016 May; 56(5):1223-9. PubMed ID: 26996808
[TBL] [Abstract][Full Text] [Related]
36. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.
Ho M; Chelly J; Carter N; Danek A; Crocker P; Monaco AP
Cell; 1994 Jun; 77(6):869-80. PubMed ID: 8004674
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
[TBL] [Abstract][Full Text] [Related]
38. Three uncommon KEL alleles in one family with unusual Kell phenotypes explain a 35-year old conundrum.
Karamatic Crew V; Poole J; Burton N; Daniels G
Vox Sang; 2014 Apr; 106(3):242-7. PubMed ID: 24795954
[TBL] [Abstract][Full Text] [Related]
39. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE
Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378
[TBL] [Abstract][Full Text] [Related]
40. The human Kell blood group binds the erythroid 4.1R protein: new insights into the 4.1R-dependent red cell membrane complex.
Azouzi S; Collec E; Mohandas N; An X; Colin Y; Le Van Kim C
Br J Haematol; 2015 Dec; 171(5):862-71. PubMed ID: 26455906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
